Potassium Ion

Potassium Ion

SCHEMBL752380

C=C([O-])C(=O)OCCC#N.[K+]

nearest known ligand 0.34

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

AGTR1DHFRGABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTNR3C2PBP2XPTGS1PTGS2VKORC1blablaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAftsImrcAmrcBmrdApbp1apbp1bpbp2apbp2bpbp3polthyA

The experimentally established mechanism targets of Potassium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.34
TSHR P16473 1/20 0.34
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25237284 0.80 MEN1 (0.39) ALDH1A1TSHRMEN1KMT2A
SCHEMBL2776281 0.79 TSHR (0.36) ALDH1A1TSHRMEN1KMT2A
SCHEMBL8940602 0.78 ALDH1A1 (0.35) ALDH1A1TSHRMEN1KMT2A
SCHEMBL5159378 0.78 ALDH1A1 (0.35) ALDH1A1TSHRMEN1KMT2A
SCHEMBL11127704 0.78 ALDH1A1 (0.59) ALDH1A1TSHRMEN1KMT2A
SCHEMBL33780 0.78 THRB (0.52) ALDH1A1TSHRMEN1KMT2A
Potassium Ion SCHEMBL5759726 0.77 MEN1 (0.33) MEN1KMT2A
SCHEMBL8701814 0.75 MEN1 (0.33) ALDH1A1TSHRMEN1KMT2A
SCHEMBL16708633 0.74 TSHR (0.37) ALDH1A1TSHRMEN1KMT2A
Acetic Acid SCHEMBL28158415 0.74 THRB (0.48) ALDH1A1TSHRMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2430013-A1 HETEROARYL COMPOUNDS AS PIKK INHIBITORS Amgen, Inc (US) 2012-03-21 EP disclosed